LivaNova PLC (LIVN) Stock Grade

About LivaNova PLC's fundamentals

LivaNova is a medical device company with a market capitalization of $4.2 billion that has demonstrated revenue growth of 10.7% year-over-year, indicating expanding sales in its core business. However, the company is currently unprofitable, reporting a net margin of -17.5% and a net loss in its latest annual statement, suggesting it is not yet converting revenue growth into bottom-line profitability. Despite these accounting losses, the company is generating positive free cash flow, which indicates that operational cash generation exceeds capital expenditure needs. With a P/E ratio of 23.7 and no dividend payment, investors are valuing the company on growth potential rather than current earnings or income returns.